3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation-Reference-Cited by-同舟云学术

3D-QSAR pharmacophore modelling, virtual screening and docking studies for lead discovery of a novel scaffold for VEGFR 2 inhibitors: Design, synthesis and biological evaluation

Published:2019-08 Issue: Volume:89 Page:102988
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Sobhy Mahitab K.,Mowafy Samar,Lasheen Deena S.,Farag Nahla A.,Abouzid Khaled A.M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference27 articles.

1. VEGF-A/VEGFR2 signaling network in endothelial cells relevant to angiogenesis;Abhinand;J. Cell Commun. Signal.,2016

2. Vascular endothelial growth factor (VEGF) receptors: drugs and new inhibitors;Musumeci;J. Med. Chem.,2012

3. Synthesis, antiangiogenesis evaluation and molecular docking studies of 1-aryl-3- [(thieno [3, 2- b ] pyridin-7-ylthio) phenyl ] ureas : Discovery of a new substitution pattern for type II VEGFR-2 Tyr kinase inhibitor;Machado;Bioorg. Med. Chem.,2015

4. J.E. Daniel S. La, Julie Belzile, James V. Bready, Angela Coxon, Thomas DeMelfi, Nicholas Doerr, A.M.L. Julie C. Flynn, Shaun R. Flynn, Russell F. Graceffa, Shawn P. Harriman, Jay F. Larrow, M.M.W. Matthew W. Martin, Michael J. Morrison, Vinod F. Patel, Philip M. Roveto, Ling Wang, J.-C.H. Douglas A. Whittington, Yohannes Teffera, Zhiyang Zhao, Anthony J. Polverino, Novel 2,3-Dihydro-1,4-Benzoxazines as Potent and Orally Bioavailable Inhibitors of Tumor-Driven Angiogenesis, J. Med. Chem. 51 (2008) 1695–1705.

5. Pharmacophore based 3D-QSAR modeling and free energy analysis of VEGFR-2 inhibitors;Rajagopalan;J. Enzyme Inhib. Med. Chem.,2013

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated pharmacophore‐based screening and docking strategy for identifying type II inhibitors of VEGFR‐2 kinase;Next Research;2024-10

2. An in silico approach to identify novel and potential Akt1 (protein kinase B-alpha) inhibitors as anticancer drugs;Molecular Diversity;2024-05-26

3. QSAR analysis of VEGFR-2 inhibitors based on machine learning, Topomer CoMFA and molecule docking;BMC Chemistry;2024-03-30

4. Novel Thiazolidine‐2,4‐Dione Derivatives as Potential VEGFR‐2 Inhibitors: Synthesis, Biological Testing, and in Silico Studies;ChemistrySelect;2024-03-15

5. Discovery of dual kinase inhibitors targeting VEGFR2 and FAK: structure-based pharmacophore modeling, virtual screening, and molecular docking studies;BMC Chemistry;2024-02-12